These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24112239)

  • 1. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.
    Pope HG; Kanayama G; Athey A; Ryan E; Hudson JI; Baggish A
    Am J Addict; 2014; 23(4):371-7. PubMed ID: 24112239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological and physical impact of anabolic-androgenic steroid dependence.
    Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
    Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic-androgenic steroid use in the United States.
    Yesalis CE; Kennedy NJ; Kopstein AN; Bahrke MS
    JAMA; 1993 Sep; 270(10):1217-21. PubMed ID: 8355384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic-androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States.
    Beaver KM; Vaughn MG; Delisi M; Wright JP
    Am J Public Health; 2008 Dec; 98(12):2185-7. PubMed ID: 18923108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic steroid abuse among teenage girls: an illusory problem?
    Kanayama G; Boynes M; Hudson JI; Field AE; Pope HG
    Drug Alcohol Depend; 2007 May; 88(2-3):156-62. PubMed ID: 17127018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.
    Kanayama G; Hudson JI; Pope HG
    Drug Alcohol Depend; 2009 Jun; 102(1-3):130-7. PubMed ID: 19339124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
    Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
    Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study.
    Havnes IA; Bukten A; Rognli EB; Muller AE
    Drug Alcohol Depend; 2020 Dec; 217():108255. PubMed ID: 32949884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys.
    Blashill AJ; Safren SA
    Pediatrics; 2014 Mar; 133(3):469-75. PubMed ID: 24488735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic androgenic steroid dependence is associated with impaired emotion recognition.
    Hauger LE; Sagoe D; Vaskinn A; Arnevik EA; Leknes S; Jørstad ML; Bjørnebekk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2667-2676. PubMed ID: 30941469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region.
    Leifman H; Rehnman C; Sjöblom E; Holgersson S
    Int J Environ Res Public Health; 2011 Jul; 8(7):2656-74. PubMed ID: 21845151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use.
    Hakansson A; Mickelsson K; Wallin C; Berglund M
    Eur Addict Res; 2012; 18(2):83-90. PubMed ID: 22286840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men.
    Lundholm L; Frisell T; Lichtenstein P; Långström N
    Addiction; 2015 Jan; 110(1):100-8. PubMed ID: 25170826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
    Kanayama G; Cohane GH; Weiss RD; Pope HG
    J Clin Psychiatry; 2003 Feb; 64(2):156-60. PubMed ID: 12633124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
    Dunn M; Mazanov J; Sitharthan G
    Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in anabolic-androgenic steroid use among adolescents.
    Yesalis CE; Barsukiewicz CK; Kopstein AN; Bahrke MS
    Arch Pediatr Adolesc Med; 1997 Dec; 151(12):1197-206. PubMed ID: 9412594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
    Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
    Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.